Medanta Share Price
(MEDANTA)
Check the latest share price of Medanta, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 02:20PM, 13 May 2025
NSE
Medanta Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹1,230Day's Price Range₹1,246.552 Week's Low
52 Week's High
₹935.552-Week Price Range₹1,430
| Returns % | |
| 1 Month Return | -3.79 % |
| 3 Month Return | + 8.75 % |
| 1 Year Return | -11.64 % |
| 3 Year Return | + 195.47 % |
| 5 Year Return | + 195.47 % |
| Market Stats | |
| Previous Close | ₹1,227.10 |
| Open | ₹1,236.80 |
| Volume | 64.80K |
| Upper Circuit | ₹1,472.50 |
| Lower Circuit | ₹981.70 |
Medanta Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹32,958.36 Cr
Return on Equity (ROE)
13.52
PE Ratio (TTM)
64.96
Return on capital employed (ROCE)
17.19
Industry PE ratio
100.16
Beta (LTM)
0.8
P/B Ratio
12.48
Dividend Yield
0PEG Ratio
31.69
Quarterly Earnings Growth YOY
15.64
EPS (TTM)
12.16
Sector
Healthcare
Book Value
90.54
Technical Analysis
Bullish
View Technical Analysis
How to invest in Medanta
Investing in Medanta is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Medanta or MEDANTA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Medanta or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Medanta with just a few clicks!
Medanta Stock's Interest Amongst Investors
Medanta Valuation
Track how the P/E of Medanta has moved over time to understand valuation trends.
Medanta in the last 5 years
Lowest (37.92x)
April 6, 2023
Today (64.96x)
May 12, 2025
Industry (100.16x)
May 12, 2025
Highest (88.30x)
February 23, 2024
Today’s Price to Earnings Ratio: 64.96x
Analysts Recommendation on Medanta
Get updated buy, sell, and hold recommendations by analysts on Medanta.
based on 15 analysts
66.67%
Buy
20.00%
Hold
13.33%
Sell
66.67% of analysts recommend a 'BUY' rating for Medanta. Average target price of ₹1278.13
Source: S&P Global Market Intelligence
Analysts Forecast on Medanta
Get share price movements and forecasts by analysts on Medanta.
Medanta price forecast by 15 analysts
Upside of4.16%
High
₹1470
Target
₹1278.13
Low
₹855
Medanta target price ₹1278.13, a slight upside of 4.16% compared to current price of ₹1236.3. According to 15 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Medanta revenue growth forecast
Expected growth rate Q1, FY2027:86.85%
Forecast
Actual
Including amortisation and stock based compensations
Medanta EPS growth forecast
EPS estimate Q1, FY2027:142.60%
Forecast
Actual
Source: S&P Global Market Intelligence
Medanta Financials
Get the annual and quarterly financial summary of Medanta, including revenue, profit, loss and more.
Medanta Index Inclusions
Medanta Earnings and Dividends
View detailed summary of the earnings and dividend history of Medanta.
Global Health Ltd Earnings Results
Global Health Ltd’s net profit jumped 15.59% since last year same period to ₹142.91Cr in the Q3 2024-2025. On a quarterly growth basis, Global Health Ltd has generated 9.23% jump in its net profits since last 3-months.
Read More about Earnings Results
Medanta Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Medanta.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 33.03% | 0.00 | |
| Foreign Institutions | 11.76% | 0.00 | |
| Mutual Funds | 10.36% | 0.00 | |
| Retail Investors | 43.28% | 0.00 | |
| Others | 1.57% | 0.00 |
Medanta vs Peers
Compare market cap, revenue, PE, and other key metrics of Medanta with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 32,958.36 | 39.09% | 0.55 | 326 | 2,694 | |
| BUY | 36,394.62 | 114.1% | 0.69 | 789 | 5,018 | |
| BUY | 51,084.24 | 93.87% | 0.54 | 645 | 7,175 |
Medanta News & Key Events
Latest news and events at one place to help you take investing decisions in Medanta.
Global Health to Establish Hospital in Guwahati - 28 Apr, 2025
Global Health Ltd, operating under the Medanta brand, announced plans to invest ₹500 crore to develop a 400-bed super specialty hospital in Guwahati, Assam, enhancing healthcare access for over 50 million people in the region.Global Health (Medanta) Positioned for Growth - 11 Apr, 2025
Global Health (Medanta) is enhancing its brand equity and operational capacity, with a new Noida hospital expected to open in six months. Analysts recommend a buy with a target price of Rs 1,390, citing improvements in ARPOB and revenue drivers.Global Health Files IPO Papers with Sebi - 10 Apr, 2025
Global Health Limited, owner of the Medanta brand, has filed for an IPO to raise Rs 500 crore. The offering includes a fresh issue and an offer for sale, with major stakeholders offloading shares. Proceeds will be used for debt repayment and corporate purposes.Global Health Secures Land for New Hospital - 08 Apr, 2025
Global Health Ltd has received a land offer from the Assam Government to establish a super speciality hospital in Guwahati, boosting investor confidence and share prices significantly.Positive Momentum for Global Health Ltd (MEDANTA) - 02 Apr, 2025
Global Health Ltd (MEDANTA) shows bullish momentum with a recommendation to buy above ₹1,235, targeting ₹1,315-1,345. The stock is rebounding, indicating steady demand and potential for further gains.
Insights on Global Health Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, MEDANTA stock has moved up by 8.8%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 106.29 Cr → 142.91 Cr (in ₹), with an average increase of 13.6% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 9.00% to 10.36% in Mar 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 33.03% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 51.6% return, outperforming this stock by 63.3%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 43.98% to 43.28% in Mar 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 974.77 Cr → 959.46 Cr (in ₹), with an average decrease of 1.6% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 12.47% to 11.76% in Mar 2025 quarter
About Medanta
issuing 500 crores in fresh issue and 1,705.57 crores in offer for sale. Finally, it came out with a public issue in November 2022, raising a total of Rs. 2,205.57 crores. Global Health Limited (GHL) is among the leading private medical care providers operating from the North and East regions of India. Founded by Dr Naresh Trehan, a renowned cardiovascular and cardiothoracic surgeon, GHL has a network of five hospitals spread across the country and provides healthcare services over 30 medical specialties. Their flagship hospital in Gurugram was opened in November 2009 and had 200 installed beds along with 50 doctors across specialties. The Patna hospital is larger and has 228 installed beds, designed to accommodate over 500, and employs over 125 doctors. To finance capital expenditure and general corporate purposes, GHL held an initial public offering in January 2021, seeking to raise 500 crores in fresh issue and 1,705.57 crores in offer for sale. The successful public issue in November 2022 allowed GHL to raise total of Rs. 2,205.57 crores.
Revenue: ₹943.44Cr as on December 2024 (Q4 24)
Net Profit: ₹142.86Cr as on December 2024 (Q4 24)
Listing date: 16 Nov, 2022
Chairperson Name: Naresh Kumar Trehan
| Organisation | Global Health Ltd |
| Industry | Healthcare |
| CEO | Naresh Kumar Trehan |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Medanta
Check out the Mutual Funds with significant holdings in Medanta.
FAQs
What is Global Health Ltd price today?
Global Health Ltd share price today stands at ₹1236.3, Open: ₹1236.8, Previous Close: ₹1227.1, High: ₹1246.5, Low: ₹1230, 52 Week High: ₹1430, 52 Week Low: ₹935.5.
How to Buy Global Health Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Global Health Ltd shares
What are today's traded volumes of Global Health Ltd?
Today's traded volume of Global Health Ltd(MEDANTA) is 64.80K.
What is today's market capitalisation of Global Health Ltd?
Today's market capitalisation of Global Health Ltd(MEDANTA) is ₹32,958.36 Cr.
What is the 52 Week High and Low Range of Global Health Ltd?
How much percentage Global Health Ltd is down from its 52 Week High?
Global Health Ltd (MEDANTA) share price is ₹1236.3. It is down -13.55% from its 52 Week High price of ₹1430
How much percentage Global Health Ltd is up from its 52 Week low?
Global Health Ltd (MEDANTA) share price is ₹1236.3. It is up 32.15% from its 52 Week Low price of ₹935.5